Zimmer Biomet Holdings (ZIM) Stock Forecast & Price Target

5 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ZIM Analyst Ratings

Moderate Buy

6 Buy

12 Hold

0 Sell

Based on 18 analysts giving stock ratings to

Zimmer

Biomet Holdings

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ZIM Stock 12 Month Forecast

Average Price Target

€92.72

▲(13.91% Upside)

Based on 18 Wall Street analysts offering 12 month price targets for Zimmer Biomet Holdings in the last 3 months. The average price target is €92.72 with a high forecast of €104.91 and a low forecast of €81.30. The average price target represents a 13.91% change from the last price of €81.40.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"66":"€66","105":"€105","75.75":"€75.8","85.5":"€85.5","95.25":"€95.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":104.90519160000001,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€104.91</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":92.72453324199999,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€92.72</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":81.30152349000001,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€81.30</span>\n  </div></div>","useHTML":true}}],"tickPositions":[66,75.75,85.5,95.25,105],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,85.68,87.1588608923077,88.6377217846154,90.11658267692309,91.59544356923078,93.07430446153847,94.55316535384617,96.03202624615386,97.51088713846154,98.98974803076923,100.46860892307693,101.94746981538462,103.42633070769232,{"y":104.90519160000001,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,85.68,86.22188717246155,86.76377434492308,87.30566151738462,87.84754868984615,88.38943586230769,88.93132303476924,89.47321020723076,90.0150973796923,90.55698455215385,91.09887172461538,91.64075889707692,92.18264606953845,{"y":92.72453324199999,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,85.68,85.34319411461539,85.00638822923078,84.66958234384616,84.33277645846155,83.99597057307693,83.65916468769231,83.3223588023077,82.98555291692308,82.64874703153846,82.31194114615386,81.97513526076924,81.63832937538463,{"y":81.30152349000001,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":89.033,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.505,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":85.441,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.605,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.962,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.7,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.964,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":77.566,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.972,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.246,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.16,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.06,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":85.68,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€104.91

Average Price Target€92.72

Lowest Price Target€81.30

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Richard Newitter

Truist Financial

€92.67

Hold

13.84%

Upside

Reiterated

09/16/26

Truist Financial Sticks to Its Hold Rating for Zimmer Biomet Holdings (ZBH)

Travis Steed

Bank of America Securities

€96.16

Hold

18.14%

Upside

Reiterated

09/08/26

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (NYSE: ABT), Pharvaris (NASDAQ: PHVS) and Zimmer Biomet Holdings (NYSE: ZBH)

Robbie Marcus

J.P. Morgan

€102.28

Hold

25.65%

Upside

Reiterated

08/17/26

J.P. Morgan Sticks to Its Hold Rating for Zimmer Biomet Holdings (ZBH)

Joanne Wuensch

Citi

€86.55

Hold

6.32%

Upside

Reiterated

08/13/26

Analysts Conflicted on These Healthcare Names: ArriVent BioPharma, Inc. (NASDAQ: AVBP), Zimmer Biomet Holdings (NYSE: ZBH) and Tecan Group AG (Other OTC: TCHBF)

Caitlin Roberts

Canaccord Genuity

€72.56→€87.42

Buy

7.40%

Upside

Reiterated

08/10/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Steven Lichtman

William Blair

―

Hold

―

Reiterated

08/06/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Zimmer Biomet Holdings (NYSE: ZBH), Enliven Therapeutics (NASDAQ: ELVN) and Encompass Health (NYSE: EHC)

Jeff Johnson

Robert W. Baird

€80.43→€90.92

Hold

11.69%

Upside

Reiterated

08/06/26

Zimmer Biomet price target raised to $104 from $92 at BairdZimmer Biomet price target raised to $104 from $92 at Baird

Pito Chickering

Deutsche Bank

€76.93→€85.67

Hold

5.25%

Upside

Reiterated

08/06/26

Deutsche Bank Reaffirms Their Hold Rating on Zimmer Biomet Holdings (ZBH)

Larry Biegelsen

Wells Fargo

€78.68→€90.04

Hold

10.62%

Upside

Assigned

08/06/26

Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (NYSE: ZBH), Cytek Biosciences (NASDAQ: CTKB) and Sight Sciences (NASDAQ: SGHT)

Vik Chopra

BMO Capital

€83.05→€83.92

Hold

3.10%

Upside

Reiterated

08/06/26

Zimmer Biomet price target raised to $96 from $95 at BMO CapitalZimmer Biomet price target raised to $96 from $95 at BMO Capital

Rick Wise

Stifel Nicolaus

€91.79→€96.16

Buy

18.14%

Upside

Assigned

08/06/26

Zimmer Biomet Holdings (ZBH) Receives a Buy from Stifel Nicolaus

Patrick Wood

UBS

€100.53→€104.91

Buy

28.88%

Upside

Reiterated

08/06/26

UBS Remains a Buy on Zimmer Biomet Holdings (ZBH)

Lee Hambright

Bernstein

€79.55→€81.3

Hold

-0.12%

Downside

Reiterated

08/06/26

Zimmer Biomet Holdings (ZBH) Gets a Hold from Bernstein

Michael Matson

Needham

―

Hold

―

Reiterated

08/05/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Geron (NASDAQ: GERN), Zimmer Biomet Holdings (NYSE: ZBH) and Recursion Pharmaceuticals (NASDAQ: RXRX)

Mathew Blackman

TD Cowen

€95.29→€100.53

Buy

23.51%

Upside

Reiterated

08/05/26

Zimmer Biomet Holdings (ZBH) Gets a Buy from TD Cowen

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Richard Newitter

Truist Financial

€92.67

Hold

13.84%

Upside

Reiterated

09/16/26

Truist Financial Sticks to Its Hold Rating for Zimmer Biomet Holdings (ZBH)

Travis Steed

Bank of America Securities

€96.16

Hold

18.14%

Upside

Reiterated

09/08/26

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (NYSE: ABT), Pharvaris (NASDAQ: PHVS) and Zimmer Biomet Holdings (NYSE: ZBH)

Robbie Marcus

J.P. Morgan

€102.28

Hold

25.65%

Upside

Reiterated

08/17/26

J.P. Morgan Sticks to Its Hold Rating for Zimmer Biomet Holdings (ZBH)

Joanne Wuensch

Citi

€86.55

Hold

6.32%

Upside

Reiterated

08/13/26

Analysts Conflicted on These Healthcare Names: ArriVent BioPharma, Inc. (NASDAQ: AVBP), Zimmer Biomet Holdings (NYSE: ZBH) and Tecan Group AG (Other OTC: TCHBF)

Caitlin Roberts

Canaccord Genuity

€72.56→€87.42

Buy

7.40%

Upside

Reiterated

08/10/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Steven Lichtman

William Blair

―

Hold

―

Reiterated

08/06/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Zimmer Biomet Holdings (NYSE: ZBH), Enliven Therapeutics (NASDAQ: ELVN) and Encompass Health (NYSE: EHC)

Jeff Johnson

Robert W. Baird

€80.43→€90.92

Hold

11.69%

Upside

Reiterated

08/06/26

Zimmer Biomet price target raised to $104 from $92 at BairdZimmer Biomet price target raised to $104 from $92 at Baird

Pito Chickering

Deutsche Bank

€76.93→€85.67

Hold

5.25%

Upside

Reiterated

08/06/26

Deutsche Bank Reaffirms Their Hold Rating on Zimmer Biomet Holdings (ZBH)

Larry Biegelsen

Wells Fargo

€78.68→€90.04

Hold

10.62%

Upside

Assigned

08/06/26

Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (NYSE: ZBH), Cytek Biosciences (NASDAQ: CTKB) and Sight Sciences (NASDAQ: SGHT)

Vik Chopra

BMO Capital

€83.05→€83.92

Hold

3.10%

Upside

Reiterated

08/06/26

Zimmer Biomet price target raised to $96 from $95 at BMO CapitalZimmer Biomet price target raised to $96 from $95 at BMO Capital

Rick Wise

Stifel Nicolaus

€91.79→€96.16

Buy

18.14%

Upside

Assigned

08/06/26

Zimmer Biomet Holdings (ZBH) Receives a Buy from Stifel Nicolaus

Patrick Wood

UBS

€100.53→€104.91

Buy

28.88%

Upside

Reiterated

08/06/26

UBS Remains a Buy on Zimmer Biomet Holdings (ZBH)

Lee Hambright

Bernstein

€79.55→€81.3

Hold

-0.12%

Downside

Reiterated

08/06/26

Zimmer Biomet Holdings (ZBH) Gets a Hold from Bernstein

Michael Matson

Needham

―

Hold

―

Reiterated

08/05/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Geron (NASDAQ: GERN), Zimmer Biomet Holdings (NYSE: ZBH) and Recursion Pharmaceuticals (NASDAQ: RXRX)

Mathew Blackman

TD Cowen

€95.29→€100.53

Buy

23.51%

Upside

Reiterated

08/05/26

Zimmer Biomet Holdings (ZBH) Gets a Buy from TD Cowen

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

MDWDMediwound

OCULOcular Therapeutix

GHGuardant Health

HROWHarrow Health

DNLIDenali Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Zimmer Biomet Holdings

3 Months

Rick WiseStifel Nicolaus

Success Rate

14/29 ratings generated profit

Average Return

+1.45%

Copying Rick Wise's trades and holding each position for 3 Months would result in 48.28% of your transactions generating a profit, with an average return of +1.45% per trade.

1 Year

Rick WiseStifel Nicolaus

Success Rate

14/29 ratings generated profit

Average Return

+4.21%

Copying Rick Wise's trades and holding each position for 1 Year would result in 48.28% of your transactions generating a profit, with an average return of +4.21% per trade.

2 Years

Vijay KumarEvercore ISI

Success Rate

6/13 ratings generated profit

Average Return

-1.38%

Copying Vijay Kumar's trades and holding each position for 2 Years would result in 46.15% of your transactions generating a profit, with an average return of -1.38% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ZIM Analyst Recommendation Trends

Rating

May 26

Jun 26

Jul 26

Aug 26

Sep 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ZIM has received 9 Buy Ratings, 21 Hold Ratings, and 0 Sell Ratings. ZIM average Analyst price target in the past 3 months is 92.72.

Each month's total comprises the sum of three months' worth of ratings.

ZIM Financial Forecast

ZIM Earnings Forecast

Next quarter’s earnings estimate for ZIM is €1.61 with a range of €1.59 to €1.64. The previous quarter’s EPS was €1.77. ZIM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ZIM has Performed in-line its overall industry.

ZIM Sales Forecast

Next quarter’s sales forecast for ZIM is €1.75B with a range of €1.74B to €1.76B. The previous quarter’s sales results were €1.86B. ZIM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ZIM has Performed in-line its overall industry.

ZIM Stock Forecast FAQ

What is DE:ZIM’s average 12-month price target, according to analysts?

Based on analyst ratings, Zimmer Biomet Holdings’s 12-month average price target is 92.72.

What is DE:ZIM’s upside potential, based on the analysts’ average price target?

Zimmer Biomet Holdings has 13.91% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Zimmer Biomet Holdings a Buy, Sell or Hold?

Zimmer Biomet Holdings has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 12 hold ratings and 0 sell ratings.

What is Zimmer Biomet Holdings’s share price target?

The average share price target for Zimmer Biomet Holdings is 92.72. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €104.91 ,and the lowest forecast is €81.30. The average share price target represents 13.91% Increase from the current price of €81.4.

What do analysts say about Zimmer Biomet Holdings?

Zimmer Biomet Holdings’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 18 Wall Streets Analysts.

How can I buy shares of Zimmer Biomet Holdings?

To buy shares of DE:ZIM, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Zimmer Biomet Holdings (ZIM) Stock Forecast & Price Target

ZIM Analyst Ratings

ZIM Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Zimmer Biomet Holdings

ZIM Analyst Recommendation Trends

ZIM Financial Forecast

ZIM Earnings Forecast

ZIM Sales Forecast

ZIM Stock Forecast FAQ

Detailed List of Analyst Forecasts